BBMRI-ERIC WEBINAR SERIES #2

Similar documents
PRIVACY ANALYTICS WHITE PAPER

IAB Europe Guidance THE DEFINITION OF PERSONAL DATA. IAB Europe GDPR Implementation Working Group WHITE PAPER

The General Data Protection Regulation and use of health data: challenges for pharmaceutical regulation

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals

WEON 2018 COREON (1) Marjolein Timmers. What is COREON? CO = Commissie (Committee) RE = Regelgeving (Regulation) ON = Onderzoek (Research)

Ministry of Justice: Call for Evidence on EU Data Protection Proposals

Biometric Data, Deidentification. E. Kindt Cost1206 Training school 2017

Data Anonymization Related Laws in the US and the EU. CS and Law Project Presentation Jaspal Singh

clarification to bring legal certainty to these issues have been voiced in various position papers and statements.

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki

Towards Code of Conduct on Processing of Personal Data for Purposes of Scientific Research in the Area of Health

Ethical Governance Framework

Global Alliance for Genomics & Health Data Sharing Lexicon

Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070

European Union General Data Protection Regulation Effects on Research

Interaction btw. the GDPR and Clinical Trials Regulation

ARTICLE 29 Data Protection Working Party

This policy sets out how Legacy Foresight and its Associates will seek to ensure compliance with the legislation.

TechAmerica Europe comments for DAPIX on Pseudonymous Data and Profiling as per 19/12/2013 paper on Specific Issues of Chapters I-IV

Big Data and Personal Data Protection Challenges and Opportunities

2

Ocean Energy Europe Privacy Policy

Ethics of Data Science

Swedish Proposal for Research Data Act

Herefordshire CCG Patient Choice and Resource Allocation Policy

Interest Balancing Test Assessment on the processing of the copies of data subjects driving licences for the MOL Limo service

Details of the Proposal

2018 / Photography & Video Bell Lane Primary School & Children s Centre

Photography and Videos at School Policy

Artificial intelligence and judicial systems: The so-called predictive justice

ITAC RESPONSE: Modernizing Consent and Privacy in PIPEDA

Guidance on the anonymisation of clinical reports for the purpose of publication

Interactive Workshop on Data Protection Impact Assessment

Privacy Policy SOP-031

Robert Bond Partner, Commercial/IP/IT

EU-GDPR The General Data Protection Regulation

ISO/IEC INTERNATIONAL STANDARD. Information technology Security techniques Privacy framework

Legal Aspects of Identity Management and Trust Services

Patient Choice and Resource Allocation Policy. NHS South Warwickshire Clinical Commissioning Group (the CCG)

EMA Technical Anonymisation Group (TAG)

CONSENT IN THE TIME OF BIG DATA. Richard Austin February 1, 2017

Castan Centre for Human Rights Law Faculty of Law, Monash University. Submission to Senate Standing Committee on Economics

Efese, ethics in research

Personal Data Protection Competency Framework for School Students. Intended to help Educators

CCTV Policy. Policy reviewed by Academy Transformation Trust on June This policy links to: T:Drive. Safeguarding Policy Data Protection Policy

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

CCTV Policy. Policy reviewed by Academy Transformation Trust on June This policy links to: Safeguarding Policy Data Protection Policy

Ethical, Legal, and Societal Implications (ELSI) in the research infrastructure context

Ethical issues raised by big data and real world evidence projects. Dr Andrew Turner

Protecting Privacy After the Failure of Anonymisation. The Paper

DISPOSITION POLICY. This Policy was approved by the Board of Trustees on March 14, 2017.

The General Data Protection Regulation

Our position. ICDPPC declaration on ethics and data protection in artificial intelligence

First Components Ltd, Savigny Oddie Ltd, & Datum Engineering Ltd. is pleased to provide the following

ICC POSITION ON LEGITIMATE INTERESTS

Continuing Healthcare Patient Choice and Resource Allocation Policy

OPINION Issued June 9, Virtual Law Office

Data Protection and Ethics in Healthcare

D2. Results of the feasibility analysis

Data Protection by Design and by Default. à la European General Data Protection Regulation

EXIN Privacy and Data Protection Foundation. Preparation Guide. Edition

The University of Sheffield Research Ethics Policy Note no. 14 RESEARCH INVOLVING SOCIAL MEDIA DATA 1. BACKGROUND

Policies for the Commissioning of Health and Healthcare

Australian Census 2016 and Privacy Impact Assessment (PIA)

The Information Commissioner s response to the Draft AI Ethics Guidelines of the High-Level Expert Group on Artificial Intelligence

4 The Examination and Implementation of Use Inventions in Major Countries

Dear Mr. Snell: On behalf of the Kansas State Historical Society you have requested our opinion on several questions relating to access to birth and d

D1.10 SECOND ETHICAL REPORT

Having regard to the Treaty establishing the European Community, and in particular its Article 286,

GDPR Implications for ediscovery from a legal and technical point of view

Diana Gordick, Ph.D. 150 E Ponce de Leon, Suite 350 Decatur, GA Health Insurance Portability and Accountability Act (HIPAA)

CILIP Privacy Briefing 2017

CODE OF CONDUCT. STATUS : December 1, 2015 DES C R I P T I O N. Internal Document Date : 01/12/2015. Revision : 02

Recast de la législation européenne et impact sur l organisation hospitalière

User Privacy in Health Monitoring Wearables

An Essential Health and Biomedical R&D Treaty

NHS CONTINUING HEALTH CARE:

From registers to personal data

Artificial Intelligence, Business, and the Law

Legal Aspects of the Internet of Things. Richard Kemp June 2017

IN VITRO DIAGNOSTICS: CAPITA EXOTICA

Workshop on anonymization Berlin, March 19, Basic Knowledge Terms, Definitions and general techniques. Murat Sariyar TMF

THE EUROPEAN DATA PROTECTION SUPERVISOR, Having regard to the Treaty on the Functioning of the European Union, and in particular Article 16 thereof,

When Must a Non-UH Investigator Seek Review by the UH IRB? the Issue of Engagement

Data Protection Regulation: Keeping Health Research Alive in the EU. A Roundtable Event Hosted by Nessa Childers MEP. European Parliament, Brussels

Commonwealth Data Forum. Giovanni Buttarelli

The new GDPR legislative changes & solutions for online marketing

Being able to make choices about your life and your care changing the law to do with mental capacity

DERIVATIVES UNDER THE EU ABS REGULATION: THE CONTINUITY CONCEPT

Mauritius. Area: 2,040 km² Population: 1.3 million Capital: Port Louis

Privacy Policy Framework

ISO/TR TECHNICAL REPORT. Intelligent transport systems System architecture Privacy aspects in ITS standards and systems

[Definitions of terms that are underlined are found at the end of this document.]

Protection of Privacy Policy

End-to-End Privacy Accountability

510 Data Responsibility Policy

Faculteit Rechtsgeleerdheid Faculteit Natuurkunde, Wiskunde en Informatica Leibniz Center for Law C-ITS and GDPR

The BioBrick Public Agreement. DRAFT Version 1a. January For public distribution and comment

EU Research Integrity Initiative

Images Policy September 2017

Transcription:

BBMRI-ERIC WEBINAR SERIES #2

NOTE THIS WEBINAR IS BEING RECORDED!

ANONYMISATION/PSEUDONYMISATION UNDER GDPR IRENE SCHLÜNDER

WHY ANONYMISE? Get rid of any data protection constraints Any processing of personal data is generally prohibited, if not explicitly permitted (Art. 6, 9 GDPR) Rec. 26 GDPR: The principles of data protection should therefore not apply to anonymous information, namely information which does not relate to an identified or identifiable natural person or to personal data rendered anonymous in such a manner that the data subject is not or no longer identifiable. This Regulation does not therefore concern the processing of such anonymous information, including for statistical or research purposes. Comply with data minimisation principle Art. 5 (c) adequate, relevant, limited, 89 (1) GDPR

WHAT IS ANONYMISED DATA? Art. 4 (1): personal data means any information relating to an identified or identifiable natural person ( data subject ); an identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person;

WHAT IS ANONYMISED DATA? Recital 26 GDPR The principles of data protection should therefore not apply to anonymous information, namely information which does not relate to an identified or identifiable natural person or to personal data rendered anonymous in such a manner that the data subject is not or no longer identifiable. Anonymous/anonymised data are non-personal data (dichotomy of data protection law)

DE FACTO ANONYMITY Rec. 26 GDPR: To determine whether a natural person is identifiable, account should be taken of all the means reasonably likely to be used, such as singling out, either by the controller or by another person to identify the natural person directly or indirectly. To ascertain whether means are reasonably likely to be used to identify the natural person, account should be taken of all objective factors, such as the costs and time required for identification, taking into consideration the available technology at the time of the processing and technological developments. Absolute anonymity once and forever is not possible and not required by the GDPR Anonymity is not a static concept, but depends on context The name Harry Smith will identify somebody in a classroom, but not globally.

RE-IDENTIFICATION OF GOUVERNEUR WILLIAM WELD Publication of health insurance data (over 45.000 clients) in Massachusetts 1997 Stripped of direct identifiers (name, address etc.) But containing full date of birth and zip code Re-Identification of Gouverneur William Weld Collapse in live-tv show Publicly known to have been hospitalised Linkage with publicly available voter data set Combination of data sets lead to unique result More medical data could be concluded from other sources Barth-Jones DC. The 'Re-Identification' of Governor W illiam W eld's Medical Information: A Critical Re-Examination of Health Data Identification Risks and Privacy Protections, Then and Now (July 2012). Available at SSRN: http://ssrn.com/abstract=2076397 https://de.wikipedia.org/wiki/william_weld

DE FACTO ANONYMITY IMPORTANT FACTORS Availability of information including context knowledge Harry Smith is not enough to identify an indiviual globally (no singling out ), but it is in a classroom Goal of a potential attacker Counting people on the street for statistical reasons versus counting bypassing reknown actors in a certain street by the yellow press Effort to achieve identification Easy access for employees of controller without great risk? Technology This test is a dynamic one and should consider the state of the art in technology at the time of the processing and the possibilities for development during the period for which the data will be processed. The system should be able to adapt to these developments as they happen, and to incorporate then the appropriate technical and organisational measures in due course (WP 136 concept of personal data, p. 15).

DE FACTO ANONYMITY The crucial factor is the re-identification risk before the background of a certain context Þ organisational measures can influence the status of anonymity Putting in place the appropriate state-of-the-art technical and organizational measures to protect the data against identification are not the consequence of a legal obligation arising from the Directive, but rather a condition for the information precisely not to be considered to be personal data and its processing not to be subject to the Directive. (WP 136, concept of personal data, p. 17) See also: Reconsidering Anonymization-Related Concepts and the Term Identification Against the Backdrop of the European Legal Framework. Biopreserv Biobank. 2016 Apr 22. http://online.liebertpub.com/doi/full/10.1089/bio.2015.0100

WHY PSEUDONYMISE? Comply with the data minimisation principle of Art. 5 (c) GDPR Personal data shall be adequate, relevant and limited to what is necessary in relation to the purposes for which they are processed ( data minimisation ); Comply with Art. 89 (1) GDPR Processing for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes, shall be subject to appropriate safeguards, in accordance with this Regulation, for the rights and freedoms of the data subject. Those safeguards shall ensure that technical and organisational measures are in place in particular in order to ensure respect for the principle of data minimisation. Those measures may include pseudonymisation provided that those purposes can be fulfilled in that manner. Where those purposes can be fulfilled by further processing which does not permit or no longer permits the identification of data subjects, those purposes shall be fulfilled in that manner.

WHAT IS PSEUDONYMISED DATA? Art. 4 (5): pseudonymisation means the processing of personal data in such a manner that the personal data can no longer be attributed to a specific data subject without the use of additional information, provided that such additional information is kept separately and is subject to technical and organisational measures to ensure that the personal data are not attributed to an identified or identifiable natural person;

WHAT IS THE DIFFERENCE BETWEEN ANONYMISATION AND PSEUDONYMISATION? The key the individual remains in principle retraceable by those who have access to the key The level of de-identification not necessarily according to the definition but very often in practice

RELATIVE ANONYMITY Is pseudonymised (coded, key-coded) data anonymous in the hands of a third party having no access to the key?

RELATIVE ANONYMITY WP 136, concept of personal data, p. 19/20: The question here is whether the data used for the clinical trial can be considered to relate to "identifiable" natural persons and thus be subject to the data protection rules. In this case, the identification of individuals (to apply the appropriate treatment in case of need) is one of the purposes of the processing of the key-coded data. The pharmaceutical company has construed the means for the processing, included the organisational measures and its relations with the researcher who holds the key in such a way that the identification of individuals is not only something that may happen, but rather as something that must happen under certain circumstances. The identification of patients is thus embedded in the purposes and the means of the processing. In this case, one can conclude that such key-coded data constitutes information relating to identifiable natural persons for all parties that might be involved in the possible identification and should be subject to the rules of data protection legislation. This does not mean, though, that any other data controller processing the same set of coded data would be processing personal data, if within the specific scheme in which those other controllers are operating reidentification is explicitly excluded and appropriate technical measures have been taken in this respect.

RELATIVE ANONYMITY European Court of Justice: C-582-14 19 October 2016 Patrick Breyer v. Bundesrepublik Deutschland http://curia.europa.eu/juris/document/document.jsf?text=&docid=184668&pageindex=0&doclang=en&mode=req&dir=&occ=first&part=1&cid=1130557 68. Just as recital 26 refers not to any means which may be used by the controller (in this case, the provider of services on the Internet), but only to those that it is likely reasonably to use, the legislature must also be understood as referring to third parties who, also in a reasonable manner, may be approached by a controller seeking to obtain additional data for the purpose of identification. This will not occur when contact with those third parties is, in fact, very costly in human and economic terms, or practically impossible or prohibited by law. Otherwise, as noted earlier, it would be virtually impossible to discriminate between the various means, since it would always be possible to imagine the hypothetical contingency of a third party who, no matter how inaccessible to the provider of services on the Internet, could now or in the future have additional relevant data to assist in the identification of a user.

SIDE-EFFECTS (ADVERSE EVENTS) OF ANONYMISATION Full (unlinked) anonymisation deprives the donor of the possibility to use their right to withdraw consent critical for WGS or other cases of weak anonymisation Makes feeding back research results or incidental findings impossible Provides the false conception, that data can be shared without safeguards (the more the data are shared and linked, the more re-identification risk increases) Often renders data useless for analysis (data mining)

THANK YOU! contact@bbmri-eric.eu www.bbmri-eric.eu @BBMRIERIC BBMRI-ERIC

Q&A ASK US WHAT YOU WANT TO KNOW